nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—Cisplatin—germ cell cancer	0.104	0.166	CbGbCtD
Etoricoxib—PTGS2—Etoposide—germ cell cancer	0.103	0.163	CbGbCtD
Etoricoxib—CYP2C19—Ifosfamide—germ cell cancer	0.0878	0.139	CbGbCtD
Etoricoxib—CYP2C9—Ifosfamide—germ cell cancer	0.073	0.116	CbGbCtD
Etoricoxib—CYP2E1—Etoposide—germ cell cancer	0.067	0.106	CbGbCtD
Etoricoxib—CYP3A4—Ifosfamide—germ cell cancer	0.0425	0.0674	CbGbCtD
Etoricoxib—CYP1A2—Etoposide—germ cell cancer	0.0387	0.0615	CbGbCtD
Etoricoxib—CYP2C9—Cisplatin—germ cell cancer	0.0355	0.0564	CbGbCtD
Etoricoxib—CYP2D6—Vinblastine—germ cell cancer	0.0354	0.0562	CbGbCtD
Etoricoxib—CYP3A4—Vinblastine—germ cell cancer	0.0225	0.0358	CbGbCtD
Etoricoxib—CYP3A4—Etoposide—germ cell cancer	0.0203	0.0322	CbGbCtD
Etoricoxib—CYP2C9—cardial valve—germ cell cancer	0.0136	0.143	CbGeAlD
Etoricoxib—MAPK14—blood vessel—germ cell cancer	0.00481	0.0506	CbGeAlD
Etoricoxib—CYP2C19—urine—germ cell cancer	0.00377	0.0397	CbGeAlD
Etoricoxib—MAPK14—neck—germ cell cancer	0.00344	0.0362	CbGeAlD
Etoricoxib—CYP1A2—urine—germ cell cancer	0.00308	0.0324	CbGeAlD
Etoricoxib—CYP2C9—urine—germ cell cancer	0.00292	0.0308	CbGeAlD
Etoricoxib—MAPK14—embryo—germ cell cancer	0.00287	0.0302	CbGeAlD
Etoricoxib—CYP2E1—urine—germ cell cancer	0.00277	0.0292	CbGeAlD
Etoricoxib—MAPK14—brainstem—germ cell cancer	0.00263	0.0277	CbGeAlD
Etoricoxib—PTGS2—appendage—germ cell cancer	0.00248	0.0261	CbGeAlD
Etoricoxib—MAPK14—telencephalon—germ cell cancer	0.00233	0.0245	CbGeAlD
Etoricoxib—CYP3A4—urine—germ cell cancer	0.00223	0.0235	CbGeAlD
Etoricoxib—MAPK14—skin of body—germ cell cancer	0.00223	0.0234	CbGeAlD
Etoricoxib—MAPK14—decidua—germ cell cancer	0.00221	0.0233	CbGeAlD
Etoricoxib—CYP2D6—urine—germ cell cancer	0.00219	0.0231	CbGeAlD
Etoricoxib—PTGS2—skin epidermis—germ cell cancer	0.00207	0.0217	CbGeAlD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.00203	0.0783	CbGpPWpGaD
Etoricoxib—MAPK14—uterus—germ cell cancer	0.00193	0.0204	CbGeAlD
Etoricoxib—MAPK14—pituitary gland—germ cell cancer	0.0019	0.02	CbGeAlD
Etoricoxib—MAPK14—adrenal gland—germ cell cancer	0.0017	0.0179	CbGeAlD
Etoricoxib—MAPK14—bone marrow—germ cell cancer	0.00164	0.0173	CbGeAlD
Etoricoxib—MAPK14—spinal cord—germ cell cancer	0.00163	0.0172	CbGeAlD
Etoricoxib—MAPK14—female gonad—germ cell cancer	0.00158	0.0166	CbGeAlD
Etoricoxib—PTGS2—endothelium—germ cell cancer	0.0015	0.0158	CbGeAlD
Etoricoxib—MAPK14—endocrine gland—germ cell cancer	0.00147	0.0155	CbGeAlD
Etoricoxib—MAPK14—head—germ cell cancer	0.00145	0.0153	CbGeAlD
Etoricoxib—MAPK14—testis—germ cell cancer	0.0014	0.0148	CbGeAlD
Etoricoxib—PTGS2—blood vessel—germ cell cancer	0.00138	0.0146	CbGeAlD
Etoricoxib—MAPK14—cerebellum—germ cell cancer	0.0013	0.0136	CbGeAlD
Etoricoxib—MAPK14—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00123	0.0474	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00111	0.0429	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00106	0.0411	CbGpPWpGaD
Etoricoxib—MAPK14—brain—germ cell cancer	0.00105	0.0111	CbGeAlD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00102	0.0396	CbGpPWpGaD
Etoricoxib—MAPK14—lymph node—germ cell cancer	0.00102	0.0107	CbGeAlD
Etoricoxib—MAPK14—Monoamine Transport—PVRL2—germ cell cancer	0.000988	0.0382	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—PHC1—germ cell cancer	0.000902	0.0349	CbGpPWpGaD
Etoricoxib—PTGS2—trigeminal ganglion—germ cell cancer	0.000854	0.00899	CbGeAlD
Etoricoxib—PTGS2—embryo—germ cell cancer	0.000825	0.00868	CbGeAlD
Etoricoxib—CYP2E1—telencephalon—germ cell cancer	0.000728	0.00767	CbGeAlD
Etoricoxib—PTGS2—telencephalon—germ cell cancer	0.000671	0.00706	CbGeAlD
Etoricoxib—CYP2D6—brainstem—germ cell cancer	0.00065	0.00684	CbGeAlD
Etoricoxib—PTGS2—skin of body—germ cell cancer	0.00064	0.00674	CbGeAlD
Etoricoxib—MAPK14—Cellular Senescence—PHC1—germ cell cancer	0.000631	0.0244	CbGpPWpGaD
Etoricoxib—CYP2C19—endocrine gland—germ cell cancer	0.000625	0.00658	CbGeAlD
Etoricoxib—CYP2E1—Metapathway biotransformation—NAT9—germ cell cancer	0.000618	0.0239	CbGpPWpGaD
Etoricoxib—CYP2D6—telencephalon—germ cell cancer	0.000577	0.00607	CbGeAlD
Etoricoxib—CYP2E1—medulla oblongata—germ cell cancer	0.000572	0.00602	CbGeAlD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.000568	0.022	CbGpPWpGaD
Etoricoxib—PTGS2—uterus—germ cell cancer	0.000556	0.00585	CbGeAlD
Etoricoxib—PTGS2—pituitary gland—germ cell cancer	0.000546	0.00575	CbGeAlD
Etoricoxib—CYP2E1—adrenal gland—germ cell cancer	0.00053	0.00558	CbGeAlD
Etoricoxib—PTGS2—medulla oblongata—germ cell cancer	0.000527	0.00555	CbGeAlD
Etoricoxib—CYP1A2—endocrine gland—germ cell cancer	0.000511	0.00538	CbGeAlD
Etoricoxib—CYP2E1—spinal cord—germ cell cancer	0.00051	0.00537	CbGeAlD
Etoricoxib—PTGS2—adrenal gland—germ cell cancer	0.000488	0.00513	CbGeAlD
Etoricoxib—CYP2C9—endocrine gland—germ cell cancer	0.000485	0.0051	CbGeAlD
Etoricoxib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000483	0.00194	CcSEcCtD
Etoricoxib—PTGS2—midbrain—germ cell cancer	0.000482	0.00507	CbGeAlD
Etoricoxib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000481	0.00193	CcSEcCtD
Etoricoxib—Urethral disorder—Cisplatin—germ cell cancer	0.00048	0.00192	CcSEcCtD
Etoricoxib—Pain—Vinblastine—germ cell cancer	0.000478	0.00192	CcSEcCtD
Etoricoxib—Constipation—Vinblastine—germ cell cancer	0.000478	0.00192	CcSEcCtD
Etoricoxib—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000477	0.0184	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—PHC1—germ cell cancer	0.000477	0.0184	CbGpPWpGaD
Etoricoxib—Confusional state—Bleomycin—germ cell cancer	0.000476	0.00191	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000472	0.00189	CcSEcCtD
Etoricoxib—PTGS2—bone marrow—germ cell cancer	0.000472	0.00497	CbGeAlD
Etoricoxib—Anaphylactic shock—Bleomycin—germ cell cancer	0.000472	0.00189	CcSEcCtD
Etoricoxib—Oedema—Bleomycin—germ cell cancer	0.000472	0.00189	CcSEcCtD
Etoricoxib—Visual impairment—Cisplatin—germ cell cancer	0.000472	0.00189	CcSEcCtD
Etoricoxib—PTGS2—spinal cord—germ cell cancer	0.00047	0.00495	CbGeAlD
Etoricoxib—Infection—Bleomycin—germ cell cancer	0.000469	0.00188	CcSEcCtD
Etoricoxib—Vision blurred—Ifosfamide—germ cell cancer	0.000466	0.00187	CcSEcCtD
Etoricoxib—Thrombocytopenia—Bleomycin—germ cell cancer	0.000462	0.00185	CcSEcCtD
Etoricoxib—MAPK14—AGE/RAGE pathway—ALPL—germ cell cancer	0.000462	0.0178	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Vinblastine—germ cell cancer	0.00046	0.00185	CcSEcCtD
Etoricoxib—CYP2E1—endocrine gland—germ cell cancer	0.000459	0.00484	CbGeAlD
Etoricoxib—Eye disorder—Cisplatin—germ cell cancer	0.000457	0.00183	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000457	0.00183	CcSEcCtD
Etoricoxib—Anaemia—Ifosfamide—germ cell cancer	0.000457	0.00183	CcSEcCtD
Etoricoxib—Tinnitus—Cisplatin—germ cell cancer	0.000456	0.00183	CcSEcCtD
Etoricoxib—PTGS2—female gonad—germ cell cancer	0.000455	0.00479	CbGeAlD
Etoricoxib—Cardiac disorder—Cisplatin—germ cell cancer	0.000454	0.00182	CcSEcCtD
Etoricoxib—Flushing—Cisplatin—germ cell cancer	0.000454	0.00182	CcSEcCtD
Etoricoxib—Agitation—Ifosfamide—germ cell cancer	0.000454	0.00182	CcSEcCtD
Etoricoxib—CYP2E1—head—germ cell cancer	0.000454	0.00477	CbGeAlD
Etoricoxib—Angioedema—Ifosfamide—germ cell cancer	0.000451	0.00181	CcSEcCtD
Etoricoxib—Anorexia—Bleomycin—germ cell cancer	0.00045	0.0018	CcSEcCtD
Etoricoxib—Diabetes mellitus—Methotrexate—germ cell cancer	0.000446	0.00179	CcSEcCtD
Etoricoxib—Hypoaesthesia—Etoposide—germ cell cancer	0.000446	0.00179	CcSEcCtD
Etoricoxib—Urinary tract disorder—Etoposide—germ cell cancer	0.000443	0.00178	CcSEcCtD
Etoricoxib—Immune system disorder—Cisplatin—germ cell cancer	0.000442	0.00177	CcSEcCtD
Etoricoxib—Abdominal pain—Vinblastine—germ cell cancer	0.000442	0.00177	CcSEcCtD
Etoricoxib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000441	0.00177	CcSEcCtD
Etoricoxib—Oedema—Dactinomycin—germ cell cancer	0.00044	0.00177	CcSEcCtD
Etoricoxib—Urethral disorder—Etoposide—germ cell cancer	0.000439	0.00176	CcSEcCtD
Etoricoxib—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000439	0.017	CbGpPWpGaD
Etoricoxib—CYP2E1—testis—germ cell cancer	0.000438	0.00461	CbGeAlD
Etoricoxib—Infection—Dactinomycin—germ cell cancer	0.000437	0.00175	CcSEcCtD
Etoricoxib—Arrhythmia—Cisplatin—germ cell cancer	0.000437	0.00175	CcSEcCtD
Etoricoxib—Palpitations—Ifosfamide—germ cell cancer	0.000437	0.00175	CcSEcCtD
Etoricoxib—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000435	0.0168	CbGpPWpGaD
Etoricoxib—Alopecia—Cisplatin—germ cell cancer	0.000432	0.00173	CcSEcCtD
Etoricoxib—Hepatic failure—Methotrexate—germ cell cancer	0.000432	0.00173	CcSEcCtD
Etoricoxib—Cough—Ifosfamide—germ cell cancer	0.000431	0.00173	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000431	0.00173	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00043	0.00172	CcSEcCtD
Etoricoxib—Hypertension—Ifosfamide—germ cell cancer	0.000427	0.00171	CcSEcCtD
Etoricoxib—Malnutrition—Cisplatin—germ cell cancer	0.000426	0.00171	CcSEcCtD
Etoricoxib—Erythema—Cisplatin—germ cell cancer	0.000426	0.00171	CcSEcCtD
Etoricoxib—Erythema multiforme—Etoposide—germ cell cancer	0.000424	0.0017	CcSEcCtD
Etoricoxib—PTGS2—endocrine gland—germ cell cancer	0.000423	0.00445	CbGeAlD
Etoricoxib—Dyspnoea—Bleomycin—germ cell cancer	0.000421	0.00169	CcSEcCtD
Etoricoxib—Chest pain—Ifosfamide—germ cell cancer	0.000421	0.00169	CcSEcCtD
Etoricoxib—Arthralgia—Ifosfamide—germ cell cancer	0.000421	0.00169	CcSEcCtD
Etoricoxib—Flatulence—Cisplatin—germ cell cancer	0.00042	0.00168	CcSEcCtD
Etoricoxib—Anorexia—Dactinomycin—germ cell cancer	0.000419	0.00168	CcSEcCtD
Etoricoxib—Eye disorder—Etoposide—germ cell cancer	0.000419	0.00168	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000418	0.00168	CcSEcCtD
Etoricoxib—PTGS2—head—germ cell cancer	0.000418	0.0044	CbGeAlD
Etoricoxib—Cardiac disorder—Etoposide—germ cell cancer	0.000416	0.00167	CcSEcCtD
Etoricoxib—Flushing—Etoposide—germ cell cancer	0.000416	0.00167	CcSEcCtD
Etoricoxib—CYP2E1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000414	0.016	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Vinblastine—germ cell cancer	0.000412	0.00165	CcSEcCtD
Etoricoxib—Decreased appetite—Bleomycin—germ cell cancer	0.00041	0.00165	CcSEcCtD
Etoricoxib—Visual disturbance—Methotrexate—germ cell cancer	0.00041	0.00164	CcSEcCtD
Etoricoxib—Muscle spasms—Cisplatin—germ cell cancer	0.00041	0.00164	CcSEcCtD
Etoricoxib—Angiopathy—Etoposide—germ cell cancer	0.000407	0.00163	CcSEcCtD
Etoricoxib—Confusional state—Ifosfamide—germ cell cancer	0.000407	0.00163	CcSEcCtD
Etoricoxib—Immune system disorder—Etoposide—germ cell cancer	0.000405	0.00162	CcSEcCtD
Etoricoxib—CYP2E1—cerebellum—germ cell cancer	0.000405	0.00426	CbGeAlD
Etoricoxib—Mediastinal disorder—Etoposide—germ cell cancer	0.000404	0.00162	CcSEcCtD
Etoricoxib—Pain—Bleomycin—germ cell cancer	0.000403	0.00162	CcSEcCtD
Etoricoxib—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000403	0.00162	CcSEcCtD
Etoricoxib—Oedema—Ifosfamide—germ cell cancer	0.000403	0.00162	CcSEcCtD
Etoricoxib—Vision blurred—Cisplatin—germ cell cancer	0.000401	0.00161	CcSEcCtD
Etoricoxib—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000401	0.00161	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000401	0.00161	CcSEcCtD
Etoricoxib—Asthenia—Vinblastine—germ cell cancer	0.000401	0.00161	CcSEcCtD
Etoricoxib—Infection—Ifosfamide—germ cell cancer	0.000401	0.00161	CcSEcCtD
Etoricoxib—Tremor—Cisplatin—germ cell cancer	0.000399	0.0016	CcSEcCtD
Etoricoxib—Alopecia—Etoposide—germ cell cancer	0.000396	0.00159	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000396	0.00159	CcSEcCtD
Etoricoxib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000395	0.00159	CcSEcCtD
Etoricoxib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000395	0.00158	CcSEcCtD
Etoricoxib—Anaemia—Cisplatin—germ cell cancer	0.000394	0.00158	CcSEcCtD
Etoricoxib—Skin disorder—Ifosfamide—germ cell cancer	0.000392	0.00157	CcSEcCtD
Etoricoxib—CYP2D6—female gonad—germ cell cancer	0.000391	0.00412	CbGeAlD
Etoricoxib—Feeling abnormal—Bleomycin—germ cell cancer	0.000389	0.00156	CcSEcCtD
Etoricoxib—Anorexia—Ifosfamide—germ cell cancer	0.000384	0.00154	CcSEcCtD
Etoricoxib—Decreased appetite—Dactinomycin—germ cell cancer	0.000383	0.00153	CcSEcCtD
Etoricoxib—Diarrhoea—Vinblastine—germ cell cancer	0.000382	0.00153	CcSEcCtD
Etoricoxib—Dysgeusia—Etoposide—germ cell cancer	0.000382	0.00153	CcSEcCtD
Etoricoxib—Fatigue—Dactinomycin—germ cell cancer	0.000379	0.00152	CcSEcCtD
Etoricoxib—Pain—Dactinomycin—germ cell cancer	0.000376	0.00151	CcSEcCtD
Etoricoxib—Muscle spasms—Etoposide—germ cell cancer	0.000375	0.00151	CcSEcCtD
Etoricoxib—Urticaria—Bleomycin—germ cell cancer	0.000375	0.0015	CcSEcCtD
Etoricoxib—PTGS2—cerebellum—germ cell cancer	0.000373	0.00392	CbGeAlD
Etoricoxib—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000372	0.0144	CbGpPWpGaD
Etoricoxib—CYP3A4—endocrine gland—germ cell cancer	0.00037	0.00389	CbGeAlD
Etoricoxib—Dizziness—Vinblastine—germ cell cancer	0.000369	0.00148	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000367	0.00147	CcSEcCtD
Etoricoxib—CYP2D6—endocrine gland—germ cell cancer	0.000364	0.00383	CbGeAlD
Etoricoxib—Feeling abnormal—Dactinomycin—germ cell cancer	0.000363	0.00145	CcSEcCtD
Etoricoxib—Anxiety—Cisplatin—germ cell cancer	0.000361	0.00145	CcSEcCtD
Etoricoxib—Anaemia—Etoposide—germ cell cancer	0.000361	0.00145	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00036	0.00145	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00036	0.00144	CcSEcCtD
Etoricoxib—Dyspnoea—Ifosfamide—germ cell cancer	0.00036	0.00144	CcSEcCtD
Etoricoxib—CYP2D6—head—germ cell cancer	0.000359	0.00378	CbGeAlD
Etoricoxib—Somnolence—Ifosfamide—germ cell cancer	0.000358	0.00144	CcSEcCtD
Etoricoxib—Vomiting—Vinblastine—germ cell cancer	0.000355	0.00143	CcSEcCtD
Etoricoxib—Breast disorder—Methotrexate—germ cell cancer	0.000351	0.00141	CcSEcCtD
Etoricoxib—Decreased appetite—Ifosfamide—germ cell cancer	0.000351	0.00141	CcSEcCtD
Etoricoxib—Headache—Vinblastine—germ cell cancer	0.00035	0.0014	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00035	0.0014	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000348	0.0014	CcSEcCtD
Etoricoxib—Abdominal pain—Dactinomycin—germ cell cancer	0.000348	0.0014	CcSEcCtD
Etoricoxib—Fatigue—Ifosfamide—germ cell cancer	0.000348	0.00139	CcSEcCtD
Etoricoxib—Oedema—Cisplatin—germ cell cancer	0.000348	0.00139	CcSEcCtD
Etoricoxib—Anaphylactic shock—Cisplatin—germ cell cancer	0.000348	0.00139	CcSEcCtD
Etoricoxib—Hypersensitivity—Bleomycin—germ cell cancer	0.000348	0.00139	CcSEcCtD
Etoricoxib—CYP2D6—testis—germ cell cancer	0.000347	0.00365	CbGeAlD
Etoricoxib—Infection—Cisplatin—germ cell cancer	0.000345	0.00139	CcSEcCtD
Etoricoxib—Pain—Ifosfamide—germ cell cancer	0.000345	0.00138	CcSEcCtD
Etoricoxib—Constipation—Ifosfamide—germ cell cancer	0.000345	0.00138	CcSEcCtD
Etoricoxib—Nervous system disorder—Cisplatin—germ cell cancer	0.000341	0.00137	CcSEcCtD
Etoricoxib—Cough—Etoposide—germ cell cancer	0.000341	0.00137	CcSEcCtD
Etoricoxib—Thrombocytopenia—Cisplatin—germ cell cancer	0.00034	0.00137	CcSEcCtD
Etoricoxib—Asthenia—Bleomycin—germ cell cancer	0.000339	0.00136	CcSEcCtD
Etoricoxib—Skin disorder—Cisplatin—germ cell cancer	0.000338	0.00135	CcSEcCtD
Etoricoxib—Hypertension—Etoposide—germ cell cancer	0.000337	0.00135	CcSEcCtD
Etoricoxib—Pruritus—Bleomycin—germ cell cancer	0.000334	0.00134	CcSEcCtD
Etoricoxib—Feeling abnormal—Ifosfamide—germ cell cancer	0.000332	0.00133	CcSEcCtD
Etoricoxib—Chest pain—Etoposide—germ cell cancer	0.000332	0.00133	CcSEcCtD
Etoricoxib—Nausea—Vinblastine—germ cell cancer	0.000332	0.00133	CcSEcCtD
Etoricoxib—Anorexia—Cisplatin—germ cell cancer	0.000331	0.00133	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00033	0.00132	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00033	0.00132	CcSEcCtD
Etoricoxib—Pancreatitis—Methotrexate—germ cell cancer	0.000329	0.00132	CcSEcCtD
Etoricoxib—CYP2E1—brain—germ cell cancer	0.000329	0.00346	CbGeAlD
Etoricoxib—Hypersensitivity—Dactinomycin—germ cell cancer	0.000324	0.0013	CcSEcCtD
Etoricoxib—MAPK14—Cell-Cell communication—PVRL2—germ cell cancer	0.000322	0.0124	CbGpPWpGaD
Etoricoxib—Abdominal discomfort—Methotrexate—germ cell cancer	0.000322	0.00129	CcSEcCtD
Etoricoxib—Confusional state—Etoposide—germ cell cancer	0.000321	0.00129	CcSEcCtD
Etoricoxib—CYP2D6—cerebellum—germ cell cancer	0.00032	0.00337	CbGeAlD
Etoricoxib—Urticaria—Ifosfamide—germ cell cancer	0.00032	0.00129	CcSEcCtD
Etoricoxib—Abdominal pain—Ifosfamide—germ cell cancer	0.000319	0.00128	CcSEcCtD
Etoricoxib—Anaphylactic shock—Etoposide—germ cell cancer	0.000318	0.00128	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000317	0.00127	CcSEcCtD
Etoricoxib—Infection—Etoposide—germ cell cancer	0.000316	0.00127	CcSEcCtD
Etoricoxib—Asthenia—Dactinomycin—germ cell cancer	0.000316	0.00127	CcSEcCtD
Etoricoxib—MAPK14—Kit receptor signaling pathway—KITLG—germ cell cancer	0.000314	0.0122	CbGpPWpGaD
Etoricoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000312	0.0121	CbGpPWpGaD
Etoricoxib—Thrombocytopenia—Etoposide—germ cell cancer	0.000312	0.00125	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000312	0.00125	CcSEcCtD
Etoricoxib—MAPK14—p38MAPK events—HRAS—germ cell cancer	0.000311	0.012	CbGpPWpGaD
Etoricoxib—Dyspnoea—Cisplatin—germ cell cancer	0.00031	0.00124	CcSEcCtD
Etoricoxib—Skin disorder—Etoposide—germ cell cancer	0.000309	0.00124	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000306	0.00123	CcSEcCtD
Etoricoxib—Anorexia—Etoposide—germ cell cancer	0.000304	0.00122	CcSEcCtD
Etoricoxib—PTGS2—brain—germ cell cancer	0.000303	0.00319	CbGeAlD
Etoricoxib—Decreased appetite—Cisplatin—germ cell cancer	0.000302	0.00121	CcSEcCtD
Etoricoxib—Diarrhoea—Dactinomycin—germ cell cancer	0.000301	0.00121	CcSEcCtD
Etoricoxib—Pneumonia—Methotrexate—germ cell cancer	0.000301	0.00121	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.0003	0.0012	CcSEcCtD
Etoricoxib—Vomiting—Bleomycin—germ cell cancer	0.0003	0.0012	CcSEcCtD
Etoricoxib—Infestation—Methotrexate—germ cell cancer	0.000299	0.0012	CcSEcCtD
Etoricoxib—Infestation NOS—Methotrexate—germ cell cancer	0.000299	0.0012	CcSEcCtD
Etoricoxib—Rash—Bleomycin—germ cell cancer	0.000297	0.00119	CcSEcCtD
Etoricoxib—Pain—Cisplatin—germ cell cancer	0.000297	0.00119	CcSEcCtD
Etoricoxib—Dermatitis—Bleomycin—germ cell cancer	0.000297	0.00119	CcSEcCtD
Etoricoxib—Hypersensitivity—Ifosfamide—germ cell cancer	0.000297	0.00119	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000297	0.00119	CcSEcCtD
Etoricoxib—Renal failure—Methotrexate—germ cell cancer	0.000294	0.00118	CcSEcCtD
Etoricoxib—PTGS2—lymph node—germ cell cancer	0.000292	0.00308	CbGeAlD
Etoricoxib—Stomatitis—Methotrexate—germ cell cancer	0.000292	0.00117	CcSEcCtD
Etoricoxib—Conjunctivitis—Methotrexate—germ cell cancer	0.000291	0.00117	CcSEcCtD
Etoricoxib—Asthenia—Ifosfamide—germ cell cancer	0.000289	0.00116	CcSEcCtD
Etoricoxib—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000287	0.0111	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Cisplatin—germ cell cancer	0.000286	0.00115	CcSEcCtD
Etoricoxib—Pruritus—Ifosfamide—germ cell cancer	0.000285	0.00114	CcSEcCtD
Etoricoxib—Haematuria—Methotrexate—germ cell cancer	0.000285	0.00114	CcSEcCtD
Etoricoxib—Dyspnoea—Etoposide—germ cell cancer	0.000284	0.00114	CcSEcCtD
Etoricoxib—Somnolence—Etoposide—germ cell cancer	0.000283	0.00114	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000283	0.00114	CcSEcCtD
Etoricoxib—Epistaxis—Methotrexate—germ cell cancer	0.000282	0.00113	CcSEcCtD
Etoricoxib—Nausea—Bleomycin—germ cell cancer	0.00028	0.00112	CcSEcCtD
Etoricoxib—Vomiting—Dactinomycin—germ cell cancer	0.00028	0.00112	CcSEcCtD
Etoricoxib—Rash—Dactinomycin—germ cell cancer	0.000277	0.00111	CcSEcCtD
Etoricoxib—Decreased appetite—Etoposide—germ cell cancer	0.000277	0.00111	CcSEcCtD
Etoricoxib—Diarrhoea—Ifosfamide—germ cell cancer	0.000276	0.00111	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000275	0.0011	CcSEcCtD
Etoricoxib—Fatigue—Etoposide—germ cell cancer	0.000275	0.0011	CcSEcCtD
Etoricoxib—Pain—Etoposide—germ cell cancer	0.000272	0.00109	CcSEcCtD
Etoricoxib—Constipation—Etoposide—germ cell cancer	0.000272	0.00109	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—germ cell cancer	0.00027	0.00108	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—germ cell cancer	0.000269	0.00108	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—germ cell cancer	0.000269	0.00108	CcSEcCtD
Etoricoxib—Dizziness—Ifosfamide—germ cell cancer	0.000267	0.00107	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—germ cell cancer	0.000266	0.00107	CcSEcCtD
Etoricoxib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000265	0.00106	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—germ cell cancer	0.000263	0.00106	CcSEcCtD
Etoricoxib—Feeling abnormal—Etoposide—germ cell cancer	0.000262	0.00105	CcSEcCtD
Etoricoxib—Nausea—Dactinomycin—germ cell cancer	0.000261	0.00105	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Etoposide—germ cell cancer	0.00026	0.00104	CcSEcCtD
Etoricoxib—CYP2D6—brain—germ cell cancer	0.00026	0.00274	CbGeAlD
Etoricoxib—Visual impairment—Methotrexate—germ cell cancer	0.000259	0.00104	CcSEcCtD
Etoricoxib—Vomiting—Ifosfamide—germ cell cancer	0.000256	0.00103	CcSEcCtD
Etoricoxib—Hypersensitivity—Cisplatin—germ cell cancer	0.000256	0.00103	CcSEcCtD
Etoricoxib—Rash—Ifosfamide—germ cell cancer	0.000254	0.00102	CcSEcCtD
Etoricoxib—Dermatitis—Ifosfamide—germ cell cancer	0.000254	0.00102	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—germ cell cancer	0.000254	0.00102	CcSEcCtD
Etoricoxib—Urticaria—Etoposide—germ cell cancer	0.000253	0.00102	CcSEcCtD
Etoricoxib—Abdominal pain—Etoposide—germ cell cancer	0.000252	0.00101	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—germ cell cancer	0.000251	0.00101	CcSEcCtD
Etoricoxib—MAPK14—FGF signaling pathway—FGFR3—germ cell cancer	0.000251	0.0097	CbGpPWpGaD
Etoricoxib—Tinnitus—Methotrexate—germ cell cancer	0.00025	0.001	CcSEcCtD
Etoricoxib—Asthenia—Cisplatin—germ cell cancer	0.000249	0.001	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—germ cell cancer	0.000249	0.001	CcSEcCtD
Etoricoxib—MAPK14—BDNF signaling pathway—ALPL—germ cell cancer	0.000247	0.00956	CbGpPWpGaD
Etoricoxib—Angiopathy—Methotrexate—germ cell cancer	0.000244	0.000977	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—germ cell cancer	0.000243	0.000973	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000242	0.000971	CcSEcCtD
Etoricoxib—Nausea—Ifosfamide—germ cell cancer	0.00024	0.000961	CcSEcCtD
Etoricoxib—Diarrhoea—Cisplatin—germ cell cancer	0.000238	0.000954	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—germ cell cancer	0.000237	0.000952	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—germ cell cancer	0.000235	0.000944	CcSEcCtD
Etoricoxib—Hypersensitivity—Etoposide—germ cell cancer	0.000235	0.000941	CcSEcCtD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.000234	0.00904	CbGpPWpGaD
Etoricoxib—Malnutrition—Methotrexate—germ cell cancer	0.000234	0.000938	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—germ cell cancer	0.000234	0.000938	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—germ cell cancer	0.000229	0.000918	CcSEcCtD
Etoricoxib—Asthenia—Etoposide—germ cell cancer	0.000229	0.000917	CcSEcCtD
Etoricoxib—Pruritus—Etoposide—germ cell cancer	0.000225	0.000904	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000225	0.00869	CbGpPWpGaD
Etoricoxib—Vomiting—Cisplatin—germ cell cancer	0.000221	0.000887	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—germ cell cancer	0.00022	0.000884	CcSEcCtD
Etoricoxib—Rash—Cisplatin—germ cell cancer	0.000219	0.000879	CcSEcCtD
Etoricoxib—Dermatitis—Cisplatin—germ cell cancer	0.000219	0.000879	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—TDGF1—germ cell cancer	0.000219	0.00846	CbGpPWpGaD
Etoricoxib—Diarrhoea—Etoposide—germ cell cancer	0.000218	0.000874	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—germ cell cancer	0.000216	0.000867	CcSEcCtD
Etoricoxib—MAPK14—Kit receptor signaling pathway—KIT—germ cell cancer	0.000215	0.00829	CbGpPWpGaD
Etoricoxib—Dizziness—Etoposide—germ cell cancer	0.000211	0.000845	CcSEcCtD
Etoricoxib—Nausea—Cisplatin—germ cell cancer	0.000206	0.000829	CcSEcCtD
Etoricoxib—Cough—Methotrexate—germ cell cancer	0.000204	0.000818	CcSEcCtD
Etoricoxib—Vomiting—Etoposide—germ cell cancer	0.000202	0.000813	CcSEcCtD
Etoricoxib—Rash—Etoposide—germ cell cancer	0.000201	0.000806	CcSEcCtD
Etoricoxib—Dermatitis—Etoposide—germ cell cancer	0.000201	0.000805	CcSEcCtD
Etoricoxib—Headache—Etoposide—germ cell cancer	0.0002	0.000801	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—germ cell cancer	0.000199	0.000798	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—germ cell cancer	0.000199	0.000798	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000198	0.000793	CcSEcCtD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—H2AFZ—germ cell cancer	0.000195	0.00754	CbGpPWpGaD
Etoricoxib—Confusional state—Methotrexate—germ cell cancer	0.000192	0.000772	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—germ cell cancer	0.000191	0.000765	CcSEcCtD
Etoricoxib—Infection—Methotrexate—germ cell cancer	0.00019	0.00076	CcSEcCtD
Etoricoxib—Nausea—Etoposide—germ cell cancer	0.000189	0.000759	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—germ cell cancer	0.000187	0.000751	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000187	0.000749	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—SALL4—germ cell cancer	0.000186	0.00719	CbGpPWpGaD
Etoricoxib—Skin disorder—Methotrexate—germ cell cancer	0.000185	0.000743	CcSEcCtD
Etoricoxib—MAPK14—p38 MAPK Signaling Pathway—MYC—germ cell cancer	0.000183	0.00709	CbGpPWpGaD
Etoricoxib—Anorexia—Methotrexate—germ cell cancer	0.000182	0.00073	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—NANOG—germ cell cancer	0.000178	0.0069	CbGpPWpGaD
Etoricoxib—MAPK14—CD40/CD40L signaling—MYC—germ cell cancer	0.000175	0.00677	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000174	0.000697	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—germ cell cancer	0.000173	0.000692	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—POU5F1—germ cell cancer	0.000172	0.00664	CbGpPWpGaD
Etoricoxib—Dyspnoea—Methotrexate—germ cell cancer	0.00017	0.000682	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—germ cell cancer	0.00017	0.00068	CcSEcCtD
Etoricoxib—MAPK14—Nanoparticle-mediated activation of receptor signaling—HRAS—germ cell cancer	0.000168	0.00651	CbGpPWpGaD
Etoricoxib—Dyspepsia—Methotrexate—germ cell cancer	0.000168	0.000674	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—germ cell cancer	0.000166	0.000665	CcSEcCtD
Etoricoxib—MAPK14—MAPK Signaling Pathway—FGF4—germ cell cancer	0.000166	0.0064	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000165	0.000661	CcSEcCtD
Etoricoxib—PTGS2—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000165	0.00636	CbGpPWpGaD
Etoricoxib—Fatigue—Methotrexate—germ cell cancer	0.000164	0.00066	CcSEcCtD
Etoricoxib—MAPK14—MAPK Cascade—HRAS—germ cell cancer	0.000164	0.00633	CbGpPWpGaD
Etoricoxib—Pain—Methotrexate—germ cell cancer	0.000163	0.000655	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—germ cell cancer	0.000157	0.000631	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000156	0.000626	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—germ cell cancer	0.000152	0.000608	CcSEcCtD
Etoricoxib—PTGS2—C-MYB transcription factor network—KITLG—germ cell cancer	0.000151	0.00585	CbGpPWpGaD
Etoricoxib—MAPK14—EPO signaling pathway—HRAS—germ cell cancer	0.000151	0.00585	CbGpPWpGaD
Etoricoxib—Abdominal pain—Methotrexate—germ cell cancer	0.000151	0.000605	CcSEcCtD
Etoricoxib—MAPK14—Alpha 6 Beta 4 signaling pathway—HRAS—germ cell cancer	0.000148	0.0057	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000147	0.00569	CbGpPWpGaD
Etoricoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—HRAS—germ cell cancer	0.000144	0.00557	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to RAS—HRAS—germ cell cancer	0.000144	0.00557	CbGpPWpGaD
Etoricoxib—MAPK14—p38 MAPK Signaling Pathway—HRAS—germ cell cancer	0.000144	0.00557	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—MYC—germ cell cancer	0.000142	0.00547	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—MYC—germ cell cancer	0.000142	0.00547	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.000141	0.00544	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Methotrexate—germ cell cancer	0.000141	0.000564	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—germ cell cancer	0.000138	0.00533	CbGpPWpGaD
Etoricoxib—Asthenia—Methotrexate—germ cell cancer	0.000137	0.000549	CcSEcCtD
Etoricoxib—MAPK14—Cellular Senescence—H2AFZ—germ cell cancer	0.000136	0.00527	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KLF4—germ cell cancer	0.000135	0.00523	CbGpPWpGaD
Etoricoxib—Pruritus—Methotrexate—germ cell cancer	0.000135	0.000542	CcSEcCtD
Etoricoxib—MAPK14—CXCR3-mediated signaling events—HRAS—germ cell cancer	0.000132	0.0051	CbGpPWpGaD
Etoricoxib—Diarrhoea—Methotrexate—germ cell cancer	0.000131	0.000524	CcSEcCtD
Etoricoxib—MAPK14—IL2-mediated signaling events—MYC—germ cell cancer	0.000127	0.0049	CbGpPWpGaD
Etoricoxib—Dizziness—Methotrexate—germ cell cancer	0.000126	0.000506	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—germ cell cancer	0.000121	0.000487	CcSEcCtD
Etoricoxib—Rash—Methotrexate—germ cell cancer	0.00012	0.000483	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—germ cell cancer	0.00012	0.000482	CcSEcCtD
Etoricoxib—Headache—Methotrexate—germ cell cancer	0.00012	0.00048	CcSEcCtD
Etoricoxib—MAPK14—Signalling to ERKs—HRAS—germ cell cancer	0.000117	0.00453	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—CD9—germ cell cancer	0.000116	0.00448	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000116	0.00447	CbGpPWpGaD
Etoricoxib—Nausea—Methotrexate—germ cell cancer	0.000113	0.000455	CcSEcCtD
Etoricoxib—MAPK14—Signaling by NGF—FGF4—germ cell cancer	0.000108	0.00418	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—MYC—germ cell cancer	0.000108	0.00417	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.000107	0.00412	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR0B1—germ cell cancer	0.000105	0.00407	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000103	0.00399	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—H2AFZ—germ cell cancer	0.000103	0.00398	CbGpPWpGaD
Etoricoxib—MAPK14—IL2-mediated signaling events—HRAS—germ cell cancer	9.95e-05	0.00385	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—TP53—germ cell cancer	9.7e-05	0.00375	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—SOX2—germ cell cancer	9.53e-05	0.00368	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	9.41e-05	0.00364	CbGpPWpGaD
Etoricoxib—MAPK14—p73 transcription factor network—MYC—germ cell cancer	9.35e-05	0.00361	CbGpPWpGaD
Etoricoxib—MAPK14—Kit receptor signaling pathway—HRAS—germ cell cancer	9.27e-05	0.00358	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	9.2e-05	0.00356	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—DNMT3L—germ cell cancer	9.13e-05	0.00353	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—germ cell cancer	8.97e-05	0.00347	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—KITLG—germ cell cancer	8.89e-05	0.00344	CbGpPWpGaD
Etoricoxib—MAPK14—Endothelins—HRAS—germ cell cancer	8.8e-05	0.0034	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	8.76e-05	0.00338	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	8.59e-05	0.00332	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	8.58e-05	0.00332	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—RARS—germ cell cancer	8.48e-05	0.00328	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—HRAS—germ cell cancer	8.48e-05	0.00328	CbGpPWpGaD
Etoricoxib—MAPK14—BCR signaling pathway—HRAS—germ cell cancer	8.38e-05	0.00324	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	8.38e-05	0.00324	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—HRAS—germ cell cancer	8.09e-05	0.00313	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	7.93e-05	0.00307	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	7.89e-05	0.00305	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—HRAS—germ cell cancer	7.65e-05	0.00296	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	7.45e-05	0.00288	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	7.23e-05	0.00279	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—HRAS—germ cell cancer	6.61e-05	0.00256	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—FGFR3—germ cell cancer	6.61e-05	0.00255	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	6.23e-05	0.00241	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—MYC—germ cell cancer	6.2e-05	0.0024	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—FGF4—germ cell cancer	6.18e-05	0.00239	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—germ cell cancer	6.11e-05	0.00236	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—KIT—germ cell cancer	6.07e-05	0.00235	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	5.85e-05	0.00226	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	5.76e-05	0.00223	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PVRL2—germ cell cancer	5.69e-05	0.0022	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	5.69e-05	0.0022	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.58e-05	0.00216	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—germ cell cancer	5.53e-05	0.00214	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—HRAS—germ cell cancer	5.44e-05	0.0021	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	5.21e-05	0.00201	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—MYC—germ cell cancer	5.11e-05	0.00198	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—germ cell cancer	5.09e-05	0.00197	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KITLG—germ cell cancer	5.07e-05	0.00196	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.61e-05	0.00178	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—HRAS—germ cell cancer	4.54e-05	0.00176	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	4.47e-05	0.00173	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	4.33e-05	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—germ cell cancer	4.2e-05	0.00162	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—HRAS—germ cell cancer	4.17e-05	0.00161	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	4.13e-05	0.0016	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	4.09e-05	0.00158	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.05e-05	0.00157	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—germ cell cancer	3.87e-05	0.0015	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.79e-05	0.00146	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—FGFR3—germ cell cancer	3.77e-05	0.00146	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC2A3—germ cell cancer	3.69e-05	0.00143	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.69e-05	0.00143	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FGF4—germ cell cancer	3.6e-05	0.00139	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	3.56e-05	0.00137	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KIT—germ cell cancer	3.46e-05	0.00134	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	3.41e-05	0.00132	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—H2AFZ—germ cell cancer	3.19e-05	0.00123	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.16e-05	0.00122	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC2A3—germ cell cancer	3.09e-05	0.0012	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC22A3—germ cell cancer	3.05e-05	0.00118	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KITLG—germ cell cancer	2.95e-05	0.00114	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.95e-05	0.00114	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—germ cell cancer	2.92e-05	0.00113	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC2A3—germ cell cancer	2.91e-05	0.00113	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC22A3—germ cell cancer	2.87e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—OXT—germ cell cancer	2.72e-05	0.00105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—HRAS—germ cell cancer	2.62e-05	0.00101	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CRABP1—germ cell cancer	2.48e-05	0.00096	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.42e-05	0.000935	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CRABP1—germ cell cancer	2.34e-05	0.000904	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGF4—germ cell cancer	2.33e-05	0.000899	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	2.25e-05	0.000868	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	2.21e-05	0.000855	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FGFR3—germ cell cancer	2.2e-05	0.000849	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGF4—germ cell cancer	2.12e-05	0.00082	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—H2AFZ—germ cell cancer	2.08e-05	0.000803	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A3—germ cell cancer	2.07e-05	0.000799	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	2.05e-05	0.000792	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC22A3—germ cell cancer	2.04e-05	0.000787	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	2.02e-05	0.00078	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KIT—germ cell cancer	2.02e-05	0.000779	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KITLG—germ cell cancer	1.91e-05	0.000738	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—H2AFZ—germ cell cancer	1.89e-05	0.000732	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AVP—germ cell cancer	1.87e-05	0.000722	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CRABP1—germ cell cancer	1.8e-05	0.000697	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.75e-05	0.000677	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KITLG—germ cell cancer	1.74e-05	0.000674	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—germ cell cancer	1.74e-05	0.000672	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.72e-05	0.000666	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—germ cell cancer	1.69e-05	0.000655	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—germ cell cancer	1.66e-05	0.000642	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.66e-05	0.000641	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.64e-05	0.000636	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—germ cell cancer	1.5e-05	0.000578	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGFR3—germ cell cancer	1.42e-05	0.000549	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.41e-05	0.000543	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.35e-05	0.000522	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.33e-05	0.000514	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KIT—germ cell cancer	1.3e-05	0.000504	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGFR3—germ cell cancer	1.3e-05	0.000501	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KIT—germ cell cancer	1.19e-05	0.00046	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—germ cell cancer	1.1e-05	0.000426	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.08e-05	0.000419	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—germ cell cancer	8.71e-06	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—germ cell cancer	7.17e-06	0.000277	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—germ cell cancer	6.54e-06	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—germ cell cancer	5.89e-06	0.000228	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—germ cell cancer	5.63e-06	0.000218	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—germ cell cancer	5.14e-06	0.000199	CbGpPWpGaD
